Nestlé to buy Pfizer’s infant-nutrition business
Swiss food and drink giant Nestlé has announced a deal to acquire Pfizer’s infant-nutrition business for $11.85 billion (SFr10.8 billion).
The Vevey-based company says the acquisition, subject to regulatory approval, would “enhance its position in global infant nutrition”.
Nestlé CEO Paul Bulcke called the deal to buy the Pfizer nutrition unit “an excellent strategic fit”.
Nestlé said in a statement on Monday that estimated sales from the acquired business would be $2.4 billion in 2012.
It said 85 per cent of those sales are in emerging markets, many of which have large, fast-growing populations.
Nestlé is one of the world’s largest sellers of infant formula and may face some antitrust hurdles to complete the deal.
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here. Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.